Weekly Roundup
COVID-19 Vaccine Development, Policy, and Public Perception in the United States
|
|
CommuniVax Corner
Our local teams continue supporting vaccine rollout efforts in their communities:
- The San Diego team's community outreach efforts have been highlighted in several recent publications. Read more about their work on ramping up testing, plans for addressing the easing of statewide mask mandates, and advice for protecting kids' health as schools and workplaces reopen. The team is also conducting targeted outreach to its local Catholic and Spanish-speaking communities.
- The team in Prince George's County, Maryland has partnered with Luminis Health to set up a vaccine clinic at a Hyattsville, MD barbershop. The effort has been covered by the University of Maryland and USA TODAY.
- The team in Idaho is placing CommuniVax student researchers at the Southeast Idaho Public Health Department to support vaccine outreach and education through the summer.
|
|
People, Perceptions, and Polls
|
|
NEWS
Adolescents Can Finally Get Vaccinated against COVID. More than 3.85 million children have tested positive for COVID-19 in the U.S. The novel coronavirus has caused more than 15,700 hospitalizations and more than 300 deaths among kids in the states and territories that have reported the data. Children have also begun making up a larger proportion of COVID-19 cases: they represent 24 percent of cases in the first week of May and 14 percent of all cases since the pandemic began, including a 4 percent increase from April 11 to May 6. (Scientific American, 5/13/21)
See also:
|
|
NEWS
Latest Data on COVID-19 Vaccinations Race/Ethnicity. As of May 17, 2021, CDC reported that race/ethnicity was known for 56% of people who had received at least one dose of the vaccine. Among this group, nearly two thirds were White (62%), 13% were Hispanic, 9% were Black, 6% were Asian, 1% were American Indian or Alaska Native, and <1% were Native Hawaiian or Other Pacific Islander, while 8% reported multiple or other race. However, CDC data also show that recent vaccinations are reaching larger shares of Hispanic, Asian, and Black populations. (KFF, 5/19/21)
See also:
|
|
NEWS
No One Actually Knows If You’re Vaccinated. It’s easy to say that customers, employees, or students need to be vaccinated, but it’s much more difficult to check that someone really is. A few states have created or promised more technical “vaccine passport” systems—usually smartphone apps connected to state databases—that could confirm people have been vaccinated against COVID-19. But many Republican-led states, including Texas, Florida, and Arizona, have opposed or even banned the implementation of any sort of vaccine verification system, mostly citing government overreach . (The Atlantic, 5/14/21)
|
|
NEWS
In New Vaccination Push, Biden Leans on His ‘Community Corps’. A slowdown in vaccinations has often been attributed to vaccine hesitancy, an opposition to or skepticism of vaccines. But a large group, about 30 million American adults, say they are open to getting a coronavirus vaccine but have not managed to do so, according to a U.S. Census Bureau estimate. Their ranks are larger than the outright hesitant. (New York Times, 5/16/21)
|
|
TOOLKIT
Toolkit to Increase Vaccine Confidence in Rural Areas. The Department of Health and Human Services has released a toolkit featuring tailored materials you can use to educate rural residents about the COVID-19 vaccines and to increase their confidence in the vaccines while reinforcing basic preventive measures. This toolkit features newly developed and culturally tailored materials, including fact sheets and an infographic, from the HHS COVID-19 public education campaign . (NACCHO, 5/14/21)
|
|
NEWS
1 million vaccine doses administered at FEMA-supported centers in the Southeast. Four centers opened March 3 in Florida, capable of providing 3,000 doses per day in Jacksonville, Miami, Orlando and Tampa. Subsequently, more centers opened in Alabama, Georgia, Kentucky, North Carolina, South Carolina and Tennessee, some with 3,000-dose capability and others with 1,000-dose capability. (FEMA, 5/11/21)
|
|
Law, Policy, and Politics
|
|
NEWS
Your Questions About Vaccines at Work, Answered. Here’s what we do know: Generally, employers are allowed to require employees to be vaccinated. The Equal Employment Opportunity Commission issued guidance in December stating that vaccine mandates are legal. But this is complicated by proposed legislation in a number of states that would restrict companies’ abilities to set such requirements, and it may be further complicated by the fact that all the vaccines only have conditional approval for emergency use . (New York Times, 5/15/21)
|
|
BLOG
It Was The Government That Produced COVID-19 Vaccine Success. In the case of vaccines in general, the government often plays an outsized role, but in the era of COVID-19 the government’s role was even more central than usual. The government essentially removed the bulk of traditional industry risks related to vaccine development: a) scientific failures, b) failures to demonstrate safety and efficacy, c) manufacturing risks; and d) market risks related to low demand . (Health Affairs, 5/14/21)
See also:
|
|
OPINION
America Is Failing Its Moral Test on Vaccines. It’s time to help the rest of the world. By marshaling this nation’s vast resources to produce and distribute enough vaccines to meet global demand, the United States would act in keeping with the nation’s best traditions and highest aspirations while advancing its geopolitical and economic interests. It is a moment of both obligation and opportunity. (New York Times, 5/14/21)
See also:
|
|
NEWS
Confusing rules, loopholes and legal issues: College vaccination plans are a mess. The introduction of three Covid-19 vaccines early this year to college populations seemed to present an exit from these patchwork reopenings, which robbed students of a traditional college experience. But an NBC News analysis of rules across the U.S. found that vaccination requirements for students have proven to be just as complicated as the frenetic fall 2020 semester, if not more so. (NBC, 5/20/21)
|
|
Research, Development, and Clinical Practice
|
|
NEWS
Sanofi, GSK announce positive early results for their Covid-19 vaccine candidate. “Our Phase 2 data confirm the potential of this vaccine to play a role in addressing this ongoing global public health crisis, as we know multiple vaccines will be needed, especially as variants continue to emerge and the need for effective and booster vaccines, which can be stored at normal temperatures increases,” Thomas Triomphe, executive vice president and head of the vaccines division at Sanofi Pasteur, said in a statement. (STAT, 5/17/21)
|
|
This newsletter supports CommuniVax, a research coalition convened by the
Johns Hopkins Center for Health Security and the Texas State University Department of Anthropology,
with support from the Chan Zuckerberg Initiative and The Rockefeller Foundation.
|
|
|
|
|
|
|